Showing results (1-10 of 33) with videos related to
Sort By:
Pageof 4
Immunotherapy|October 22, 2013
Immunotherapy for high-grade glioma: how to go beyond Phase I/II clinical trialsStefaan van GoolNeuroradiology|November 7, 2007
Paediatric neuroradiological aspects of Langerhans cell histiocytosisPhilippe Demaerel, Stefaan Van GoolInternational Journal of Molecular Sciences|November 11, 2022
Counteracting Immunosuppression in the Tumor Microenvironment by Oncolytic Newcastle Disease Virus and Cellular ImmunotherapyVolker Schirrmacher, Stefaan van Gool, Wilfried StueckerBiomedicines|September 5, 2019
Breaking Therapy Resistance: An Update on Oncolytic Newcastle Disease Virus for Improvements of Cancer TherapyVolker Schirrmacher, Stefaan van Gool, Wilfried StueckerBiomedicines|April 27, 2024
Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single InstitutionVolker Schirrmacher, Stefaan Van Gool, Wilfried StueckerExpert Review of Neurotherapeutics|November 13, 2013
Myeloid-derived suppressor cells in gliomaMasoud Mirghorbani, Stefaan Van Gool, Nima RezaeiImmunotargets and Therapy|July 30, 2016
Dendritic cell vaccination for glioblastoma multiforme: review with focus on predictive factors for treatment responseJoost Dejaegher, Stefaan Van Gool, Steven De VleeschouwerJournal of Immunology (Baltimore, Md. : 1950)|June 12, 2016
Regulatory T Cell-Dependent and -Independent Mechanisms of Immune Suppression by CD28/B7 and CD40/CD40L Costimulation BlockadeIsabel Vogel, Bert Verbinnen, Stefaan Van Gool, et al.Surgical Neurology|March 1, 2005
Long-term survival in a child with a brain stem dermoid cystFrank van Calenbergh, Philippe Demaerel, Raf Sciot, et al.Clinical & Developmental Immunology|May 28, 2013
Depletion of regulatory T cells in a mouse experimental glioma model through anti-CD25 treatment results in the infiltration of non-immunosuppressive myeloid cells in the brainWim Maes, Tina Verschuere, Anaïs Van Hoylandt, et al.Pageof 4